UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000023629
Receipt number R000027115
Scientific Title Baseline characteristics of patients with COPD (chronic bronchitis, emphysema) who require LABA and LAMA (both free and fixed combination) for maintenance therapy other than tiotropium+olodaterol fixed dose combination (Tio+Olo FDC) assessed in parallel with the PMS of Tio+Olo FDC Respimat, BI trial number 1237.34
Date of disclosure of the study information 2016/08/21
Last modified on 2020/08/24 19:06:24

No. Disposal Last modified on Item of update
1 Insert 2016/08/15 13:10:43
2 Update 2016/08/16 12:48:58 Key inclusion criteria
Key inclusion criteria
3 Update 2016/09/16 13:48:00 Recruitment status
Date of protocol fixation
4 Update 2017/06/23 08:40:15 Recruitment status
5 Update 2017/08/16 12:32:14 Recruitment status
6 Update 2017/08/16 12:33:37 Recruitment status
7 Update 2018/02/14 12:20:49 Recruitment status
8 Update 2018/10/31 09:45:18 Last follow-up date
9 Update 2018/12/13 14:28:03 Last name of lead principal investigator
Last name of lead principal investigator
Division name
Division name
TEL
Email
Last name of contact person
Last name of contact person
Division name
Division name
TEL
Email
Name of person sending information
Name of person sending information
Division name
Division name
TEL
Email
10 Update 2020/08/24 18:37:22 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
11 Update 2020/08/24 18:41:34 Organization
Organization
Address
Address
Tel
Email
12 Update 2020/08/24 19:02:17 Organization
Organization
Address
Tel
Email
13 Update 2020/08/24 19:05:06 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
14 Update 2020/08/24 19:05:58 Recruitment status
Date of IRB
15 Update 2020/08/24 19:06:24 Publication of results